We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Assertio Holdings Inc
39 own
21 watching
Current Price
$0
$0.13
(3.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
194.23M
52-Week High
4.44
52-Week Low
1.86
Average Volume
1.77M
Dividend Yield
--
P/E Ratio
--
Market Capitalization194.23M52-Week High4.4452-Week Low1.86Average Volume1.77MDividend Yield--P/E Ratio--What does the Assertio Holdings Inc do?
Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, it is involved in the clinical development of Cebranopadol for the treatment of chronic nociceptive and neuropathic pain. The company sells its products to wholesalers and retail pharmacies. It also has a portfolio of license agreements based on its proprietary Acuform gastroretentive drug delivery technology with Mallinckrodt Inc.; Ironwood Pharmaceuticals, Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 1995 and is headquartered in Newark, California.
Read More
How much money does Assertio Holdings Inc make?
News & Events about Assertio Holdings Inc.
Globe Newswire
16days ago
SYMPAZAN (clobazam) oral film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and olderOral film delivery from SYMPAZAN delivers clobazam to LGS patients with no crushing, no mixing, no prep work LAKE FOREST, Ill., Jan. 17, 2023 (GLOBE ...
Globe Newswire
3 months ago
WARREN, N.J., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing current standards of care to solve patients problems through simplifying complex delivery methods, announced today a transaction to license Sympazan (clobazam) oral film to...
Globe Newswire
3 months ago
Trailing 12 Month Revenues of Sympazan Were $9.5 MillionAssertio Paid $9.0 Million Upfront, Additional $6.0 Million upon Patent Allowance LAKE FOREST, Ill., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a specialty pharmaceutical company offering...
Accesswire
4 months ago
RALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be presenting to a global investor...
Globe Newswire
4 months ago
LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, will host investor meetings September 14, 2022 as part ...
Frequently Asked Questions
Frequently Asked Questions
What is Assertio Holdings Inc share price today?
Can Indians buy Assertio Holdings Inc shares?
How can I buy Assertio Holdings Inc shares from India?
Can Fractional shares of Assertio Holdings Inc be purchased?
What are the documents required to start investing in Assertio Holdings Inc stocks?
What is today’s traded volume of Assertio Holdings Inc?
What is today’s market capitalisation of Assertio Holdings Inc?
What is the 52-Week High and Low Range of Assertio Holdings Inc?
What percentage is Assertio Holdings Inc down from its 52-Week High?
What percentage is Assertio Holdings Inc up from its 52-Week Low?
Current Price
$0
$0.13
(3.23%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.